SYNA.NASDAQSynaptics INC

Form 4: SYNAPTICS Director Vivie Lee Boosts Equity Stake

Sentiment:

Insider Transaction Report


SYNAPTICS Director Vivie Lee acquired 3,036 shares of common stock, increasing her beneficial ownership to 10,958 shares.

Summary

  • Vivie Lee, a Director of SYNAPTICS Inc. (SYNA), acquired 3,036 shares of common stock.
  • The transaction occurred on November 3, 2025.
  • The acquisition price was $0 per share, indicating a grant or award of restricted stock units.
  • Following this transaction, Vivie Lee beneficially owns 10,958 shares of SYNAPTICS common stock.
  • The acquired restricted stock units will vest one-fourth each quarter until fully vested on November 3, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders if the Director is not standing for re-election.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and potential confidence in the company's future performance.

Positives

  • A Director's acquisition of shares, even through a grant, aligns their interests with shareholders and can signal confidence in the company's future performance.

Future Outlook

The restricted stock units are scheduled to vest quarterly, with full vesting by November 3, 2026, or the date of the 2026 Annual Meeting of Stockholders for Directors not seeking re-election, indicating a long-term incentive structure and commitment.

Industry Context

This Form 4 filing reports an insider transaction, which is a routine disclosure for public companies when directors or officers acquire or dispose of company stock. It does not provide broader industry trends but reflects an individual director's equity position and compensation structure within the company.

Related Party Transactions

  • Acquisition of 3,036 shares of common stock by Director Vivie Lee from SYNAPTICS Inc. as part of an equity compensation plan.

Stakeholder Impact

  • Shareholders: Increased alignment of a director's interests with shareholders due to increased equity ownership.
  • Management: Reinforces the incentive structure for directors, linking their compensation to company performance.

Next Steps

  • Continued vesting of restricted stock units quarterly until November 3, 2026.
  • Potential re-election of Director Vivie Lee at the 2026 Annual Meeting of Stockholders.

Key Dates

DateDescription
11/03/2025Date of transaction for the acquisition of 3,036 shares of common stock by Director Vivie Lee.
11/04/2025Signature date of the reporting person's attorney-in-fact.
11/03/2026Full vesting date for the restricted stock units, vesting one-fourth each quarter.

Recommendation

hold

The acquisition of additional shares by a director, even through a grant, generally signals confidence in the company's long-term prospects and aligns management interests with shareholders. While not a direct open-market purchase, it strengthens the director's stake. This information alone is not sufficient for a 'buy' or 'sell' recommendation, but it provides a positive signal for existing holders.

Keywords

SYNAPTICS, SYNA, Vivie Lee, Director, stock acquisition, insider trading, Form 4, restricted stock units, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.